Clinical trial
Monitoring the HeMAtological TOXicity of Drugs
NCT03828942 is registered in ClinicalTrials.gov with Groupe Hospitalier Pitie-Salpetriere as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Monitoring the HeMAtological TOXicity of Drugs
- Lead sponsor
- Groupe Hospitalier Pitie-Salpetriere
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 1, 2019
- Completion date
- April 8, 2023
- Enrollment
- 1,000 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
hematological abnormality, hematotoxicity